- Jiyya
- Shaidun
- Neuroblastoma
- Ciwon daji mai ƙarfi
- Shaidun
- TILS
- Maganin Kwayoyin NK
- Myasthenia Gravis (MG)
- Ciwon sankarar lymphoblastic mai tsanani (B-ALL)
- Tsarin Lupus Erythematosus (SLE)
- Ciwon sankarar lymphoblastic mai tsanani (T-ALL)
- Lymphoma na Non-Hodgkin (NHL)
- Myeloma da yawa (MM)
- Babban Lymphom na B-cell da aka Yaɗu
- B-lymphocytic Leukemia
- Myeloma
Mr. C----Limfoma Mai Large B-cell (DLBCL)
Wannan majiyyaci, Mista C, ya fito daga Indiya kuma yana da shekaru 55. A farkon shekarar 2019, ya kamu da cutar lymphadenopathy mai tsanani kuma ya nemi kulawar likita a asibitinmu. An gudanar da bincike mai zurfi, wanda ya kai ga gano cutar Diffuse Large B-Cell Lymphoma (DLBCL). Ganin yadda DLBCL ke da tsauri, fara magani nan take yana da matukar muhimmanci don magance matsalar yadda ya kamata.
Kafin a yi masa maganin CAR-T, Mista C ya yi gwaje-gwaje da dama a asibitin marasa lafiya da suka haɗa da nau'ikan maganin chemotherapy daban-daban. Da farko, ya karɓi RCHOP a matsayin maganin farko, sannan aka yi masa magani daga baya, ciki har da REPOCH, R2-ICE, GEMOX-BTKi, Pola-BR, GB261, TQB2916, GA 101-Cedarbenamine-Doxil, da kuma Inotuzumab. Duk da cewa an yi wa waɗannan jiyya na tsawon lokaci kuma sun nuna wani tasiri, sun kasa cimma nasarar shawo kan cututtuka, wanda hakan ya nuna irin ƙarfin halin Mr. C's DLBCL.
Ganin rashin samun amsa mai gamsarwa ga magungunan gargajiya da kuma ci gaban da yanayinsa ke samu cikin sauri, an gano Mista C a matsayin wanda zai yi gwajin maganin ƙwayoyin CAR-T. Bayan an yi masa gwaje-gwaje na shirye-shirye masu kyau, Mista C ya yi gwajin ƙwayoyin CAR-T a farkon shekarar 2020. Wannan sabuwar hanyar magani ta ƙunshi gyara ƙwayoyin T na majiyyaci don kai hari ga ƙwayoyin cutar kansa yadda ya kamata.
Kwanaki ashirin da takwas bayan sake haɗa ƙwayoyin CAR-T, an lura da gagarumin sauyi ga cututtuka, wanda ke nuna nasarar maganin. Wannan sakamakon ya kawo sabon bege da kyakkyawan fata ga Mista C da ƙungiyar kula da lafiyarsa. Amsar da aka bayar ga maganin CAR-T ta nuna yuwuwar maganin rigakafi wajen magance cututtukan jini masu tsanani kamar DLBCL.
A nan gaba, Mista C zai ci gaba da sanya ido da kuma bin diddigin marasa lafiyarsa domin ya kula da lafiyarsa sosai. Tsarin kula da cututtuka na dogon lokaci da kuma kwanciyar hankali su ne muhimman manufofin shirin kula da lafiyarsa na ci gaba. Nasarar da aka samu sakamakon maganin CAR-T ya nuna muhimmancin hanyoyin da aka keɓance da kuma sabbin hanyoyin magance cututtukan daji masu rikitarwa, wanda hakan ke ba marasa lafiya kamar Mista C damar samun ci gaba mai kyau.

Kafin & kwanaki 28 bayan
bayanin2
Submit An Free Inquiry
Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

